52个符合Gavi资格的低收入和中等收入国家的疫苗金融风险保护:一项建模研究
Boshen Jiao1,2,3, Ryoko Sato3, Joshua Mak3,4
1Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, California, United States of America.
PLoS medicine
|November 4, 2025
概括
疫苗显著降低了灾难性的医疗支出,保护了数百万人免于贫困,特别是在低收入和中等收入国家. 麻疹疫苗为最贫困人口提供了相当大的财务风险保护.
科学领域:
- 全球健康 全球健康
- 卫生经济学 卫生经济学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 减轻贫困是一个关键的全球发展目标.
- 疫苗通过预防疾病和相关的医疗保健费用,提供潜在的财务风险保护 (FRP).
- 这项研究估计了低收入和中等收入国家 (LMICs) 主要疫苗的终身FRP益处.
研究的目的:
- 量化主要疫苗对金融风险保护的好处.
- 估计疫苗预防的灾难性卫生支出 (CHE) 病例的数量.
- 评估疫苗对LMICs减贫的影响.
主要方法:
- 开发了一个微模拟模型来量化疫苗预防的CHE病例.
- 使用了有关减少感染,医疗保健支出和疾病成本的数据.
- 该模型考虑了52个符合Gavi资格国家的乙型肝炎,Hib,轮状病毒,麻疹和肺炎球菌疫苗.
主要成果:
- 疫苗在2000年至2030年期间共同避免了大约2亿个CHE病例.
- 在最贫穷的人口五分之一中,大约一半的CHE病例得到了预防.
- 麻疹疫苗显示出显著的影响,避免了4400万个CHE病例,特别是在最贫穷的五分之一.
结论:
- 疫苗提供了大量的FRP,特别是在弱势群体中.
- 在LMICs疫苗接种计划的投资有助于改善健康和减少贫困.
- 持续的疫苗接种工作对于弱势群体实现健康和经济效益至关重要.
相关概念视频
Relative Risk
1.8K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
395
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
395
Vaccinations
51.2K
Overview
51.2K
Bioequivalence studies: Biowaivers
214
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
214
Bias in Epidemiological Studies
1.3K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.3K
Cancer Vaccines
945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945


